Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Am I missing something but doesn't this patent protect 273?https://globenewswire.com/news-release/2015/08/12/760035/0/en/Anavex-Receives-Notice-of-Allowance-for-U-S-Patent-Application-Related-to-ANAVEX-2-73.html
How about smart $$$ picking up shares at 1 buck pre split!
Do you have a link?
Follow the $$$$$... "we get no respect"
Why hasn't IR set up some interviews with influential groups/people?
Not only is the science being dissed but most times they point to the size of the study choosing not to understand the adaptive approach.
My understanding has a;ways been that 371 advances the science of 273.
Of course I my off base on this.
Anavex has a patent for 371 (super 273)
Did you ever have the feeling that the world was against you...well being an Anavex shareholder I can understand that. The pressures from the big $$$ BP are endless, even Michele Sullivan had to put out a tweet expressing caution after publishing a very positive article. As I have said in the past this is a long term investment and the science has been proving out beyond my expectations. Following the daily rise and fall of the SP has not been for the weak of heart. My advice is to turn off your computer and enjoy your favorite adult beverage.... Anavex will be a winner!
Don't expect much from Crammer... he is part of the Cabal and is bought and paid for by BP
Thank You... You made my day.
When we get approval..that will not be a problem!
We need to make this video go viral...I have tweeted it to all network news and to the Donald
Keep in mind the Aussies are not hindered by BP..
I never said LPC replaces BP. I said the good doctor has not accepted their offers. Decided to go it alone with Rett. I also believe the Aussies will more than help with PH 2/3 AD, based on them announcing trials to begin in 2017.
We have the funds to support Rett.
Jimmy You nailed it!
I believe, the offers coming from BP were unacceptable and the Good Doctor sees the most cost effective and fastest path to commercialization is via Rett. He tapped the LPC funding to accomplish this. In the long run this will benefit us shareholders much more than if we sold out to BP now. In my mind this was always a long term investment. Ignore all the noise and be patient
We never knew about the last grant till long after the fact.
Could it be that the Aussies have committed to fund PH 2/3... They have already announced that a 300 patient trial will be held in 2017.
Great post Jon...It is just a matter of time and I believe time is on our side....
Believe it.... It's all about the $$$$$ ...follow the $$$$
I agree. Waiting with baited breath..
Shouldn't Biogen have the results of their 273 MS investigation by now?
I remember reading this should not take more than a few weeks to complete.
Not a problem..Today was a great Day regardless of what happens Monday. The Good Doctor has delivered. AD is too much of an international problem for our little company to be ignored.
I guess I read it differently.
He also said...
He also took issue with another design approach that has recently gained favor in the field:
adaptive trials where decisions are made on whether to proceed with a given compound or dose
based on cognitive assessments done at early, interim time points. Adaptive trials have proven to
be very powerful for diseases such as cancer where there are clear and hard biomarkers of
disease progression. But Aisen said that measures of cognition are too noisy to predict, at an
early time point, what the final outcome will be.
He bashed adaptive trials... looks like BIIB and Lily line his pockets
A keynote speaker stuck in the past...http://www.ctad-alzheimer.com/sites/ctad.prod/files/files/Keynote%20Aisen.pdf
They could have used some of their data in the presentation.
It all depends on what media coverage we get... IMO
Overall this looked very good...I found slide 2 interesting..
Paid speaker fees: Eli Lilly, Janssen-Cilag,
Lundbeck
Consultancy fees: Eli Lilly
Over $5 starts the short squeeze... IMO
Yes, 11:45 eastern
My understanding is that based on sec rules they need to release news that is “materially important” to everyone
They will have to PR the information when released to the conference.
TA 101... We busted thru a major trendline yesterday.... Blue skies smiling at us!
Could the "imaginary" CABAL have over played their hand? Longs not selling and new retail afraid to invest based on what has happened before.
As far as I know this data was not made available....be careful this may be a pumper making stuff up.